| Azithromycin |
Capsule |
|
|
Refer to USP |
|
|
2016/12/22 |
| Azithromycin |
Oral Suspension |
II (Paddle) |
50 |
Phosphate buffer, pH 6.0 |
900 |
10, 20, 30, and 45 |
2006/08/17 |
| Azithromycin |
Suspension (Extended Release) |
II (Paddle) |
50 |
Phosphate Buffer, pH 6.0 |
900 |
15, 30, 45, 60, 120 and 180 |
2008/04/15 |
| Baclofen |
Tablet (Orally Disintegrating) |
II (Paddle) |
25 |
50 mM Acetate Buffer, pH 4.5 |
500 mL (10 mg) or 1000 mL (20mg) |
5, 10, 15 and 30 |
2008/07/14 |
| Baclofen |
Suspension |
II (Paddle) |
25 |
0.01 N HCl |
500 |
5, 10, 15, 30, 45 and 60 |
2024/05/31 |
| Baclofen |
Granules |
II (Paddle) |
50 |
0.01 N HCl |
500 |
5, 10, 15 and 30 |
2024/02/05 |
| Baclofen |
Tablet |
|
|
Refer to USP |
|
|
2009/12/15 |
| Baloxavir Marboxil |
Tablet |
II (paddle) |
50 |
20 mg: Phosphate Buffer, pH 6.8 with 0.07% w/v (CTAB); 40 mg: Phosphate Buffer, pH 6.8 with 0.16% w/v CTAB; 80 mg: Phosphate Buffer, pH 6.8 with 0.40 w/v cetyltrimethylammonium bromide (CTAB) |
900 |
5, 10, 15, 20, 30 and 45 |
2023/07/07 |
| Baloxavir Marboxil |
For Suspension |
II (Paddle) |
25 |
Phosphate Buffer, pH 6.8 containing 0.16% w/v cetyl trimethylammonium bromide (CTAB) |
900 |
5, 10, 15, 20 and 30 |
2023/02/09 |
| Balsalazide Disodium |
Capsule |
II (Paddle) with sinker |
50 |
pH 6.8 buffer |
900 |
10, 20, 30, and 45 |
2006/01/26 |
| Balsalazide Disodium |
Tablet |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Barcitinib |
Tablet |
II (Paddle) |
75 |
Acetate Buffer, pH 4.5 |
900 |
5, 10, 15, 20, 30, 45 and 60 |
2026/05/22 |
| Baricitinib |
Tablet |
II (Paddle) |
75 |
Acetate buffer pH 4.5 |
900 |
5, 15, 30, 45 |
2023/03/30 |
| Bedaquiline Fumarate |
Tablet |
I (Basket) |
150 |
0.01 N HCl |
900 |
10, 15, 20, 30 and 45 |
2013/06/06 |
| Belzutifan |
Tablet |
II (Paddle) |
50 |
50 mM potassium phosphate buffer at pH 6.5 with 68 mM potassium chloride (@37°C) |
900 |
10, 15, 20, 30, 45 and 60 |
2023/07/07 |
| Bempedoic Acid |
Tablet |
II (Paddle) |
50 |
0.05 M Phosphate buffer, pH 6.6 |
900 |
5, 10, 15, 20 and 30 |
2021/08/19 |
| Bempedoic Acid/Ezetimibe |
Tablet |
II (Paddle) |
50 |
Bempedoic Acid: 0.05 M Phosphate buffer, pH 6.6; Ezetimibe: 0.05M Sodium
Acetate Buffer pH 4.5 with 0.45% SLS |
900 |
5, 10, 15, 20, 30, and 45 |
2021/08/19 |
| Benazepril HCl |
Tablet |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Benazepril HCl/Hydrochlorothiazide |
Tablet |
I (Basket) |
100 |
0.1 N HCl |
500 |
10, 20, 30 and 45 |
2004/01/16 |
| Bendroflumethiazide/Nadolol |
Tablet |
|
|
Refer to USP |
|
|
2007/07/25 |